title: Comparison of patency and cost-effectiveness of self-expandable metal and plastic stents used for malignant biliary strictures: a Polish single-center study.
abstract: BACKGROUND
  Most patients with malignant biliary obstruction are suited only for palliation by endoscopic drainage with plastic stents (PS) or self-expandable metal stents (SEMS).
  
  
  OBJECTIVE
  To compare the clinical outcome and costs of biliary stenting with SEMS and PS in patients with malignant biliary strictures.
  
  
  METHODS
  A total of 114 patients with malignant jaundice who underwent 376 endoscopic retrograde biliary drainage (ERBD) were studied.
  
  
  RESULTS
  ERBD with the placement of PS was performed in 80 patients, with one-step SEMS in 20 patients and two-step SEMS in 14 patients. Significantly fewer ERBD interventions were performed in patients with one-step SEMS than PS or the two-step SEMS technique (2.0±1.12 vs. 3.1±1.7 or 5.7±2.1, respectively, P<0.0001). The median hospitalization duration per procedure was similar for the three groups of patients. The patients' survival time was the longest in the two-step SEMS group in comparison with the one-step SEMS and PS groups (596±270 vs. 276±141 or 208±219 days, P<0.001). Overall median time to recurrent biliary obstruction was 89.3±159 days for PS and 120.6±101 days for SEMS (P=0.01). The total cost of hospitalization with ERBD was higher for two-step SEMS than for one-step SEMS or PS (1448±312, 1152±135 and 977±156&OV0556;, P<0.0001). However, the estimated annual cost of medical care for one-step SEMS was higher than that for the two-step SEMS or PS groups (4618, 4079, and 3995&OV0556;, respectively).
  
  
  CONCLUSIONS
  Biliary decompression by SEMS is associated with longer patency and reduced number of auxiliary procedures; however, repeated PS insertions still remain the most cost-effective strategy.
authors.affiliation: Department of Gastroenterology and Hepatology, Medical University of Silesia, Katowice, Poland.
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Budzyńska
authors.forename: Ewa
authors.initials: E
authors.lastname: Nowakowska-Duława
authors.forename: Tomasz
authors.initials: T
authors.lastname: Marek
authors.forename: Marek
authors.initials: M
authors.lastname: Hartleb
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002760:Cholangiopancreatography, Endoscopic Retrograde / Q000009:adverse effects / Q000191:economics* / Q000295:instrumentation* / Q000401:mortality; D002779:Cholestasis / Q000000981:diagnostic imaging / Q000191:economics* / Q000401:mortality / Q000628:therapy*; D003251:Constriction, Pathologic; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D019299:Decompression, Surgical / Q000009:adverse effects / Q000191:economics* / Q000295:instrumentation* / Q000401:mortality; D004322:Drainage / Q000009:adverse effects / Q000191:economics* / Q000295:instrumentation* / Q000401:mortality; D005260:Female; D017721:Hospital Costs; D006801:Humans; D007902:Length of Stay / Q000191:economics; D008297:Male; D008670:Metals / Q000191:economics*; D008875:Middle Aged; D010969:Plastics / Q000191:economics*; D011044:Poland; D011474:Prosthesis Design; D012008:Recurrence; D012189:Retrospective Studies; D015607:Stents / Q000191:economics*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D008670:Metals; D010969:Plastics